检索

标题
作者
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Dorofeeva L.
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M., Ametov A., Zilov A., Antsiferov M., Ametov A., Zilov A.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M., Antsiferov M.
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
The many faces of vitamin D
Verbovoy A., Dolgikh Y., Verbovaya N.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A., Lomonova T., Sharonova L.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N., Antsiferov M., Dorofeeva L.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M., Koteshkova O.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E., Rashid M., Antsiferov M.
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T., Demidova T.
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N., Panenko S., Golubeva A.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E., Antsiferov M.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O., Zanozina O.
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G., Novikova L.
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y., Zanozin A., Zanozina O., Runov G.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N., Ivanova L., Abaeva F.
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E., Danilova T.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I., Romantsova T., Glinkina I., Romantsova T.
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A., Rudakova A.
Advance - movement forward
Petunina N., Petunina N.
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.
Carbohydrate metabolism disorders and osteoporosis
Alekseeva N.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N., Mishra O., Antsiferov M.
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A., Tertychnaya E.
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L., Lomova A., Ruyatkin D.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M., Antsiferov M.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
101 - 177 的 177 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##